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Fructus Ligustri Lucidi (FLL), a kidney-tonifying Chinese herb, was shown to regulate Ca balance in ovariectomized (OVX) rats in our previous
study. This study investigated whether it could improve bone properties in aged normal and OVX rats and increase osteoblastic differentiation in
rat osteoblast-like UMR-106 cells. Ten-month-old aged rats underwent sham-operation or ovariectomy, were orally administered with FLL extracts
or its vehicle and fed with diets containing different levels of Ca (LCD, 0·1 % Ca; MCD, 0·6 % Ca; HCD, 1·2 % Ca) for 12 weeks. Ovariectomy
induced bone loss at multiple-sites of both tibia and femur in all rats being studied. FLL extract increased bone mineral density and bone mineral
content at both tibial and femoral diaphysis as well as the lumbar vertebra (LV-2) in rats fed either LCD or MCD. In addition, FLL increased
biomechanical strength of the tibial diaphysis in these rats. Combination of FLL and high-Ca diet significantly improved bone mass of cortical
and trabecular bone at appendicular bones and LV-2 and decreased bone loss associated with ovarietomy and low-Ca feeding. Treatment of
UMR-106 cells with FLL extracts accelerated the formation of calcified matrix and increased extracellular Ca and P depositions in time- and
dose-dependent manner. The level of mineralization reached a maximum by 6 d incubation at the dosage of 10mg FLL extract/ml. Our study indi-
cated that FLL extract could improve bone properties in aged rats possibly via its direct action on osteoblastic cells by enhancement of the min-
eralization process.
Fructus Ligustri Lucidi: Ovariectomy: Bone: UMR-106: Mineralization
Traditional Chinese medicine has been widely used for thou-
sands of years to treat fractures and joint diseases. Many
herbs shown to have kidney-tonifying activities are used in
traditional Chinese medicine formulae for prevention and
treatment of osteoporosis1. Although these herbal medicines
are regarded as cost-effective alternatives by their traditional
users, their international acceptance as a major regimen for
prevention and treatment of osteoporosis require extensive
research using modern science.
The source of the crude drug, Fructus Ligustri Lucidi (FLL,
Chinese name, Nvzhenzi), is the fruit of Ligustrum lucidum
Ait2. It has been used in traditional Chinese medicine for
over 1000 years, mainly to treat ailments such as menopausal
problems, blurred vision, tinnitus, rheumatic pains, palpita-
tions, backache, insomnia as well as to alleviate age-related
symptoms3 – 5. In the theory of traditional Chinese medicine,
it has the effects of maintaining healthy energy and nourishing
the liver and kidneys. It is therefore a commonly prescribed
herbal material in a number of formulae used to tonify the kid-
neys and strengthen bone6,7.
Modern research has shown that FLL is useful for preven-
tion of bone-marrow loss in cancer patients receiving che-
motherapy8 and could increase estrogen receptor (ER)ß
mRNA expression in amygdale of male rats9. Hao et al.
observed that FLL induced ultrastructural changes on the cor-
ticotrophs of rat pituitary gland and provided morphological
evidence for the action of FLL in modulating endocrine func-
tion10. Our previous study indicated that Ca balance was
improved and Ca absorption rate was elevated in ovari-
ectomized (OVX) rats treated with FLL11,12.
*Corresponding author: Dr Man-Sau Wong, fax (852) 23649932, email bcmswong@polyu.edu.hk
Abbreviations: BMC, bone mineral content; BMD, bone mineral density; FLL, Fructus Ligustri Lucidi; LV, lumbar vertebra; OVX, ovariectomized; LCD, MCD and
HCD, low- medium- and high-Ca diets respectively.
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Ca homeostasis is regulated by complex hormonal signals
in vivo, including parathyroid hormone, 1,25-dihydroxyvitamin
D3 and calcitonin
13 – 15. Organ systems that are actively involved
in maintaining Ca homeostasis include the parathyroid gland for
sensing serum Ca level, duodenum for active Ca absorption from
diet, kidney for Ca reabsorption, as well as bone for maintaining
extracellular fluid Ca level13 – 15. Our previous results demon-
strated that FLL could improve Ca balance, suggesting that
FLL might act directly on the axis of Ca homeostasis. However,
it is unclear whether the improvement of Ca balance by FLL
extract would result in bone-protective effects and whether the
effects of FLL extract will be influenced by dietary Ca levels.
Thus, the current study was designed to investigate the protec-
tive effect of FLL extract on bones in oestrogen-replete and oes-
trogen-depleted rats fed diets containing different level of Ca.
To study the action of FLL on bone formation, rat osteoblastic
UMR-106 cells were used. UMR-106 cells share a number of
phenotypic properties with mature osteoblasts. These similarities
include morphological appearance, responsiveness to calciotro-
pic agents, and a relative high level of expression of cell surface
alkaline phosphatase activity16. The formation of a calcified
extracellular matrix in a controlled cell-mediated manner signi-
fies the final stage of osteoblast differentiation and bone
formation17,18. Thus, to determine whether FLL induced osteo-
blastic differentiation and bone formation, its effects on minera-
lized matrix formation in UMR-106 cells were studied.
The present study was conducted to investigate whether
FLL extract exerts protective effects on bone mass and bone
strength in aged sham-operated and OVX rats fed diets with
different dietary Ca level. The direct effects of FLL extract
on mineralization and extracellular mineral content in UMR-
106 cells were also evaluated.
Materials and methods
Preparation of Fructus Ligustri Lucidi extract
FLL was obtained from the Jiangsu province of China. A vou-
cher specimen was deposited in the school of Chinese medicine,
the Chinese University of Hong Kong. The dried and powdered
(25 kg) of the crude plant was extracted with 70 % ethanol twice,
the preparation was filtered and concentrated under vacuum to
produce a viscous residue at a yield of 38·1 %, by weight of
the starting materials. For in vivo studies 15 ml portions of
extract were stored at 2208C until use when they were diluted
tenfold with distilled water. For in vitro studies the extract
powder was prepared by freeze drying, stored in the desiccator
and reconstituted on the day of use with sterilized water.
Oleanolic acid and ursolic acid are the two main active com-
pounds in FLL and oleanolic acid is a commonly used marker for
authentication of FLL according to the Chinese Pharmacopoeia.
Fig. 1 shows a typical chromatographic profile including stan-
dard samples and FLL extract. Oleanolic acid and ursolic acid
were adequately resolved from other unknown compounds and
could be clearly identified by retention time, confirming the
identity of the FLL extract.
Animal experiment
Female, retired breeder Sprague-Dawley rats (Experimental
Animal Centre of Guangdong province, Guangzhou, China)
were used in this study. The rats had six previous reproductive
cycles and were about 11 months of age at the beginning of
the study. The rats were housed in a room which provided alter-
nating 12 h periods of light and dark with the room temperature
at 23 ^ 18C and humidity 55 ^ 5 %. Rats (n 120) were divided
randomly into two groups and subjected to operation as follows:
sham-operation (Sham, n 60) and ovariectomy (OVX, n 60).
During recovery from operation, all rats were fed medium-Ca
diet (MCD, TD 98 005, 0·6 % Ca, 0·65 % P) for 10 d before the
treatment regimen was initiated. Both the Sham and OVX rats
were then randomly and equally divided into three groups and
fed with diets containing different levels of Ca: low-Ca diet
(LCD, TD 05 004, 0·1 % Ca, 0·65 % P), MCD and high-Ca diet
(HCD, TD 05 005, 1·2 % Ca, 0·65 % P). The nutritional compo-
sition of the different diets is shown in Table 1. Sham and OVX
rats fed with diets containing different level of Ca were treated
orally with either FLL extracts (700 mg/kg) or its vehicle for
12 weeks. Animal grouping is shown in Table 2. The body
weight of the animals was recorded weekly for adjusting admin-
istration of FLL. At sacrifice, the tibias and femurs were col-
lected, cleaned of all soft tissue, wrapped together with intact
lumbar vertebra in saline-soaked towels, and stored at 2208C
for further analysis. The experimental protocol was approved
by the Animal Ethic Committee of the Hong Kong Polytechnic
University.
Bone mass determination in rat tibia, femur and lumbar
vertebra
Tibias, femurs and lumbar vertebra were thawed at room tem-
perature before testing, and bone mass was measured by periph-
eral quantitative computerized tomography with an XCT2000
machine (Norland Stratec Medizintechnik GmbH, Birkenfeld,
Germany) aided by specially designed software for small ani-
mals. Cone Phantom (Slice 1, 787 mm2; Slice 2, 0·539 1/cm;
Slice 3, 0·333 1/cm; Slice 4, 0·436 1/cm) and Standard Phantom
(0·436 1/cm) were scanned to calibrate the instrument. The exact
position of the tibia within the gantry core of the XCT machine
was visualized with a fan beam from a 58 kV X-ray source with a
current of 0·178 mA. The site chosen for scanning was composed
mainly of trabecular bone and was located 2·5 mm distal to the
proximal end and the distal end, and the intermediate scan for
cortical bone was centred on the mid-shaft of long bone.
The intact lumbar vertebra 2 (LV-2) was also measured. Anal-
ysis of these scans produced measurement of volumetric bone
mineral density (BMD) and bone mineral content (BMC).
Fig. 1. Reverse-phase HPLC for the qualitative analysis of oleanolic acid and
ursolic acid in the ethanol extract of Fructus Ligustri Lucidi (FLL). The chro-
matograms shown are for standard samples (oleanolic acid (---.) and ursolic
acid (. . .) and FLL extract (——).
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Humidity was maintained at 50 % to 60 % during the measure-
ments. CV obtained for BMD of the same long bone and spine
bone after repositioning five times were 0·78 % and 0·89 %,
respectively.
Bone strength of rat tibia
Rat tibias then underwent a three-point bending mechanical
test on Hounsfield material testing machine (Model H10KM,
Hounsfield Test Equipment Limited, Surrey, UK) to determine
maximal load (N, a measure of the maximum force that the
bone withstood before fracture) and stiffness (N/mm, a
measure of the extrinsic rigidity of the bone). Each specimen
was placed on two supports spaced 15 mm apart and the load
was applied to the bone midway between the supports at a
deformation rate of 2 mm/min until fracture occurred. The
tibias were positioned such that bending occurred about the
medial–lateral axis. Load-deformation curves were recorded
during the bending process.
Cell culture
UMR-106 cells, a clonal osteoblastic cell line derived from rat
osteosarcoma (ATCC no. CRL-1661), were routinely cultured
in Dulbecco’s modified Eagle medium supplemented with 5 %
fetal bovine serum, penicillin (100 U/ml) and streptomycin
(100mg/ml). Dulbecco’s modified Eagle medium, fetal
bovine serum, and penicillin–streptomycin were purchased
from Life Technologies Inc (Carlsbad, California, USA). At
about 80 % confluence, cells were seeded in a 96-well micro-
titer plate (Falcon, Becton-Dickinson, Franklin Lakes, NJ,
USA) and 12-well plate (NUNC, Roskilde, Denmark) at a
density of 5 £ 103 and 6 £ 104 cells/well, respectively. Upon
confluence in the 96-well plate, cells were starved in serum-
free Dulbecco’s modified Eagle medium for another 24 h.
Cells were then treated with FLL extract at 0·1mg/ml, 1mg/
ml, 10mg/ml and 100mg/ml for 24 h or 48 h. Cells were cul-
tured at 378C in a humidified atmosphere of 95 % air and
5 % CO2.
Cell- proliferation assay
The medium was removed and 10ml of the combined 3-(4,5-
dimethy1-2-yl)-5-(-3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium (MTS)/phenazine methosulfate (PMS) (Promega,
Madison, WI, USA) solution was added to each well of the
96-well plate containing 90ml PBS. The plate was incubated for
1 h at 378C in a humidified humidified atmosphere of 95 % air
and 5 % CO2. The absorbance at 490 nm was recorded using an
ELISA plate reader.
Nodule formation
Upon confluence in 6-well multiplates, cells were cultured in
mineralizing medium (Dulbecco’s modified Eagle medium
supplemented with 5 % fetal bovine serum, 10 mM sodium
ß-glycerophosphate, 50 ug/ml ascorbic acid and FLL extracts;
the final concentration was the same as for cell-proliferation
tests) and were refreshed at 3-d intervals. Nodule was stained
with Alizarin red (Chemical Reagents Corp., Beijing, China)
for detection of Ca deposit on day 3 and day 6. Briefly, cells
were washed twice with PBS, fixed for 1 h at 48C in 70 %
ethyl alcohol, and subjected to staining with Alizarin red sol-
ution (0·1 %) for 10 min at room temperature. Nonspecific
staining was removed by repeated washing using water.
Table 1. Diet composition
Low-Ca diet* (1 g Ca/kg diet) Medium-Ca diet† (6 g Ca/kg diet) High-Ca diet‡ (12 g Ca/kg diet)
Casein 110·0 110·0 110·0
Egg-white solids, spray-dried 97·9 97·9 97·9
DL-Methionine 3·0 3·0 3·0
Sucrose 563·5803 551·0903 536·0803
Corn starch 100·0 100·0 100·0
Corn oil 50·0 50·0 50·0
Cellulose 20·0 20·0 20·0
Vitamin mix§ 10·0 10·0 10·0
Mineral mixturek 0·042 0·042 0·042
* Harlan Teklad, Madison, WI. Low Calcium Diet (LCD, TD #05 004). This formula is a modification of TD #98 005 to reduce Ca to 0·1 %.
† Harlan Teklad, Madison, WI. Control Diet (MCD, TD #98 005). This formula is a modification of TD #86 464.
‡ Harlan Teklad, Madison, WI. High Calcium Diet (HCD, TD #05 005). This formula is a modification of TD #98 005 to increase Ca to 1·2 %.
§ Vitamin mixture from Harlan Teklad (#40 060) provided (mg/kg diet): p-aminobenzoic acid, 110·1; ascorbic acid, coated, 1016·6; biotin, 0·44; vitamin B-12, 29·7; calcium pan-
tothenate, 66·1; choline dihydrogen citrate, 3496·9; folic acid, 1·98; inositol, 110·1; menadione, 49·5; niacin, 99·1; pyridoxine HCl, 22·0; riboflavin, 22·0; thiamin HCl, 22·0; dry
vitamin A retinyl palmitate (500,000 U/g), 39·65; dry cholecalciferol (500,000 U/g), 4·4; dry vitamin E DL-a-tochopherol acetate (500 U/g), 242·3; cornstarch (diluent), 4666·9.
kMineral mixture from Harlan Teklad provided (mg/kg diet): potassium phosphate, monobasic, 24·6; calcium carbonate, 14·74 for MCD, 2·25 for LCD and 29·75 for HCD; pot-
assium chloride, 5·6; sodium bicarbonate, 4·62; magnesium oxide, 3·83; sodium chloride, 3·7; sodium selenite, 0·5; ferric citrate, 0·21; manganous carbonate, 0·123; zinc
carbonate, 0·056; chromium potassium sulfate (12H2O), 0·0193; cupric carbonate, 0·011; and potassium iodate, 0·0004.
Table 2. Animal grouping, according to operation (OVX, ovari-
ectomized), administration (FLL, Fructus Ligustri Lucidi) and diet (LCD,
low-Ca diet; MCD, medium-Ca diet; HCD, high-Ca diet)
Group Operation Administration Diet
SVL Sham Vehicle LCD
SVM Sham Vehicle MCD
SVH Sham Vehicle HCD
SFL Sham FLL LCD
SFM Sham FLL MCD
SFH Sham FLL HCD
OVL OVX Vehicle LCD
OVM OVX Vehicle MCD
OVH OVX Vehicle HCD
OFL OVX FLL LCD
OFM OVX FLL MCD
OFH OVX FLL HCD
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Determination of extracellular Ca and P deposits
Upon medium removal, cells were washed twice with distilled
water. Five hundred microlitres HCl (1M) was added to each
well in 6-well plate. The well was rinsed with another
500ml HCl (1M) and the solutions were pooled. Cell debris
was removed by brief centrifugation. Ca and P ion concen-
trations in the extracellular matrix were determined by com-
mercial kits (Zhongsheng Beikong Bio-technology and
Science Inc, Beijing, China).
Statistical analysis
The data from these experiments is reported as means with
their standard errors for each group. Analysis of the effects
of herb and OVX as grouping variables was performed by
two-way ANOVA at each dietary Ca level and the effect of
different Ca diets as one intervention was also analyzed by
two-way ANOVA both in Sham rats and in OVX rats. Inter-
group differences were analyzed by one-way ANOVA, fol-
lowed by using Tukey’s post hoc test to compare the group
means (GraphPad PRISM, version 4.0). Values of P,0·05
were considered statistically significant.
Results
Bone mass in rat tibia
Two-way ANOVA analysis (Table 3) showed that (1) ovari-
ectomy significantly induced bone loss of proximal metaphysis
(P, 0·001) and diaphysis (P, 0·05) at all dietary Ca levels and
distal metaphysis (P, 0·01) at LCD and MCD; (2) different Ca-
containing diets produced marked influence on BMD (P, 0·05)
and BMC (P, 0·05) of tibial diaphysis in Sham rats, moreover,
there was the interaction (P, 0·05) between Ca diets and FLL
administration on the two parameters; (3) dietary Ca restriction
resulted in the decline (P, 0·01) of BMD of tibial distal meta-
physis in OVX rats; (4) FLL did not alter BMD at either proximal
metaphysis or distal metaphysis of tibia in rats fed diet of any Ca
level; (5) FLL could significantly increase BMD (P ¼ 0·0355)
and BMC (P ¼ 0·0476) of the tibal diaphysis in rats fed LCD,
as well as increase BMC (P ¼ 0·0047) of the tibal diaphysis in
rats fed MCD. No improvement on bone mass of tibal diaphysis
was observed in rats fed HCD. As shown in Fig. 2, FLL signifi-
cantly increased BMC at tibal diaphysis in Sham rats fed LCD
(v. vehicle- treated group, P, 0·05) and MCD (v. vehicle treated
group, P , 0·01), whereas FLL did not alter bone mass at any
scanning sites of the tibia in all OVX rats. However, it should
Table 3. Bone mass measured by peripheral quantitative computerized tomography in rat tibia
(Mean values and standard errors for between six and eight rats per group)
Proximal metaphysis
BMD (mg/cm3)
Diaphysis BMD
(mg/cm3)
Diaphysis BMC
(mg/cm3)
Distal metaphysis BMD
(mg/cm3)
Group§ Mean SEM Mean SEM Mean SEM Mean SEM
LCD
SVL 602·8 45·4 1152 17 5·63a 0·15 875·6 44·5
OVL 435·2 35·9 1132 7 5·26 0·12 694·8 27·6
SFL 576·8 32·0 1190 13 6·09b 0·13 850·0 19·9
OFL 460·1 21·3 1152 14 5·67 0·17 759·3 25·7
Two-way ANOVA (P value)
FLL 0·9867 0·0355* 0·0476* 0·5305
OVX 0·0002*** 0·0361* 0·0487* 0·0001***
MCD
SVM 638·2 21·0 1181 16 5·72c 0·12 850·5 27·8
OVM 459·9 34·9 1144 7 5·49 0·10 767·6 27·7
SFM 675·4 45·5 1205 13 6·68d 0·18 923·6 39·0
OFM 432·1 9·3 1163 18 5·63 0·27 777·0 39·6
Two-way ANOVA (P value)
FLL 0·8775 0·1379 0·0047** 0·2269
OVX ,0·0001*** 0·0086** 0·0012** 0·0020**
HCD
SVH 645·5 24·4 1216 14 6·61 0·19 879·2 37·7
OVH 496·0 23·2 1155 15 5·88† 0·24 823·3† 36·7
SFH 587·1 38·2 1191 14 6·21 0·33 845·4 31·6
OFH 492·1 17·5 1158† 11 5·88† 0·25 836·1††† 14·3
Two-way ANOVA (P value)
FLL 0·2570 0·4276 0·4330 0·7476
OVX ,0·0001*** 0·0019** 0·0498* 0·3235
Effect of different dietary Ca level (P value)
Sham 0·1803 0·0470* (,0·05‡) 0·0257* (,0·01‡‡) 0·7146
OVX 0·1113 0·4936 0·1124 0·0057
LCD, low-Ca diet; MCD, medium-Ca diet; HCD, high-Ca diet; FLL, Fructus Ligustri Lucidi; OVX, ovariectomized; S, Sham; O, OVX; V, Vehicle; F, FLL; L, LCD; M, MCD; H,
HCD; BMD, bone mineral density; BMC, bone mineral content.
§ Inter-group differences were analyzed by one-way ANOVA, followed by Tukey’s post hoc test.
abcd Mean values in columns of the same dietary-Ca level with unlike superscript letter are significantly different: abP , 0·05; cdP , 0·01.
*P , 0·05, **P , 0·01, ***P , 0·001, statistical analysis by two-way ANOVA.
†P , 0·05, ††† P , 0·001, compared with rats in OVL group.
‡P , 0·05, ‡‡P , 0·01, P value in parentheses shows the interaction between Ca diets and FLL feeding.
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be noted that both HCD alone (P , 0·05) and co-treatment of
FLL and HCD (P , 0·05) could prevent LCD-induced bone
loss at the diaphysis and distal metaphysis of tibia in OVX rats
(v. vehicle-treated LCD fed OVX rats).
Bone mass in rat femur
Two-way ANOVA analysis (Table 4) indicated that (1) ovari-
ectomy significantly decreased BMD of femoral proximal
(P , 0·01) and distal (P , 0·001) metaphysis and reduced
BMD and BMC of femoral diaphysis (P , 0·01) at all dietary
Ca levels; (2) no statistically significant effect of different Ca-
containing diet on bone mass at any bone site was found either
in Sham rats or in OVX rats; (3) similar to the effects on rat
tibia, FLL treatment did not alter the bone mass of the proximal
and distal metaphysis of the rat femur; (4) FLL treatment signifi-
cantly increased BMC (P ¼ 0·0377) of femoral diaphysis in rats
fed LCD and increased BMD (P ¼ 0·0121) and BMC
(P ¼ 0·0418) of femoral diaphysis in rats fed MCD. As shown
in Fig. 3, FLL treatment increased BMC of femoral diaphysis
in Sham rats fed LCD (v. SVL group, P , 0·05) and increased
BMD of femoral diaphysis in OVX rats fed MCD (v. OVM
group, P , 0·05). In contrast, FLL did not alter bone mass in
Sham and OVX rats fed HCD, suggesting that high-Ca diet feed-
ing might mask the positive effect of FLL on bone mass.
BMD in rat lumbar vertebra
The effects of ovariectomy, FLL and different dietary Ca level
on BMD of the LV-2 in rats fed diets containing different
level of Ca are shown in Table 5. Two-way ANOVA analysis
indicated that (1) ovariectomy produced significant decrease
of spine BMD in rats at each dietary Ca level (P , 0·05,
Table 5); (2) low-Ca feeding decreased BMD of spine in Sham
rats (P , 0·01, Table 5); (3) FLL treatment resulted in statisti-
cally significant elevation of BMD in LV-2 in rats fed LCD
(P, 0·05, Table 5). As shown in Fig. 4, BMD of LV-2 was sig-
nificantly increased by FLL-treatment in both Sham (P, 0·05)
and OVX (P, 0·05) rats fed LCD (v. vehicle-treated rats). How-
ever, no obvious change was observed in rats fed MCD and HCD
in response to FLL treatment (v. vehicle-treated group, NS),
regardless of their levels of oestrogen in vivo. It should be
noted that both high-Ca diet alone (P , 0·05) and in combi-
nation with FLL (P , 0·01) could significantly elevate BMD
of LV-2 in rats regardless of their oestrogen level (v. vehicle-
treated rats fed LCD).
Bone strength in rat tibia
Two-way ANOVA showed that (1) ovariectomy led to the
reduction of the maximal load (P, 0·01, Table 6) and stiffness
(P , 0·05, Table 6) at tibial diaphysis in rats fed MCD; (2)
dietary Ca deficiency has significant effect on the maximal
load (P , 0·01) and stiffness (P , 0·001) of tibial diaphysis
in Sham rats, while this effect interplayed with FLL adminis-
tration (Table 6); (3) FLL treatment increased the maximal
load of tibia diaphysis in rats fed MCD (P , 0·05, Table 6),
and the stiffness of tibia diaphysis in rats fed LCD (P , 0·05,
Table 6) and MCD (P , 0·01, Table 6). As shown in Fig. 5, in
response to FLL treatment, the maximal load and stiffness of
Sham rats fed MCD were elevated by 12·0 % (P , 0·05) and
32·6 % (P , 0·01), respectively. Similarly, FLL increased the
maximal load and stiffness of OVX rats fed LCD by 20·3 % (P
, 0·05) and 22·2 % (P , 0·05), respectively. In contrast, FLL
treatment did not alter the bone strength of tibial diaphysis in
Sham rats and OVX rats fed HCD.
Effect of Fructus Ligustri Lucidi treatment on osteoblastic cell
functions
The effect of FLL on osteoblastic cell proliferation was stu-
died by treatment of rat osteoblastic UMR-106 cells with
FLL extract at the concentration of 0·1–100mg/ml for 24
and 48 h. The results showed that FLL did not alter cell
proliferation, and higher doses did not result in cytotoxic
effect in UMR-106 cells (data not shown). To evaluate the
effects of FLL on mineralization, UMR-106 cells were incu-
bated in mineralizing medium upon confluence. Upon staining
with Alizarin red for extracellular calcified matrix, it was
found that mineralization began to occur after 3d incubation
and became nearly complete after 6d incubation. The result
clearly showed that the densities of calcified deposits as
observed under light microscopy increased with increasing
concentration of FLL extracts (data not shown). As shown
in Fig. 6, extracellular Ca and P levels of UMR-106 cells trea-
ted by FLL extract (10mg/ml) were both significantly elevated
by day 3 and their levels were significantly increased by 1-2
fold in UMR-106 cells treated with 1–100mg/ml by day 6.
The increase in extracellular mineral content of UMR-106
cells by FLL extract (0·1mg/ml to 10mg/ml) was dose-depen-
dent with a maximum at 10mg/ml.
Fig. 2. (a) Bone mineral density (BMD) and (b) bone mineral content (BMC)
of tibial diaphysis. Measurements for treatment groups (S, Sham; O, ovari-
ectomized; V, Vehicle; F, Fructus Ligustri Lucidi) on different diets (LCD, low-
Ca diet (L); MCD, medium-Ca diet; HCD, high-Ca diet) shown are: , SV; ,
SF; , OV; , OF. Values are expressed as means with standard errors
indicated by vertical bars (n 6–8). Inter-group differences were analyzed by
one-way ANOVA, followed by Tukey’s post hoc test. *P , 0·05; **P , 0·01,
v. V-treated group receiving similar treatment; †P , 0·05, v. OVL.
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Discussion
The present study is the first to evaluate the effect of the
ethanol extract of FLL on bone properties in aged normal
and OVX rats. Our results indicated that significant improve-
ment of bone mass by FLL could be found at the diaphysis of
tibia and femur in aged rats fed either LCD or MCD, but not
in those fed HCD. These results suggest that the effect of FLL
on bone mass was influenced by the level of dietary Ca intake.
Our results also indicated that the effects of FLL extract on
bone were site-specific as it could only preserve bone mass
and bone strength at the diaphysis in the appendicular bones
as well as BMD in the lumbar spine, but not at the proximal
metaphysis and distal metaphysis of the appendicular bones
in aged rats. In addition, the loss of bone mass at the diaphysis
and distal metaphysis of appendicular bones induced by LCD
and ovariectomy in aged rats could also be protected by co-
treatment with HCD and FLL. Most importantly, the results
from our in vitro studies provide additional evidence for the
protective effects of FLL on bone as enhancement of matrix
ossification was found in rat osteoblast-like UMR-106 cells
treated with FLL extract.
Appendicular bone loss induced by ovariectomy was much
more prominent than that by Ca-deplete diet in this study,
demonstrated by the significant reduction of BMD of
cancellous bone and cortical bone in OVX rats shown in
Tables 3 and 4, which was inconsistent with our previous
reports13,19. In addition, detrimental effects of Ca restriction
on appendicular bone quality were more serious in OVX
rats than that in Sham rats, which could be attributed to, at
least partially, our recent observation that ovariectomy wor-
sens secondary hyperparathyroidism in mature rats during
LCD13.
In addition, it appeared that appendicular bone loss at the
tibia diaphysis caused by ovariectomy in rats fed all levels
of dietary Ca only resulted in the change of bone strength
in rats fed MCD, but not in those fed LCD or HCD. These
results suggest that the significant change in bone mass by
ovariectomy might not lead to a change in bone strength in
rats. As bone mass is not the only determinant of bone
strength, our results suggest that dietary Ca intake might
alter other determinants such as bone microarchitecture that
results in the protection against the loss of bone strength in
rats fed LCD or HCD.
In our previous study, we demonstrated that FLL extract
could suppress the induction of bone turnover markers by
ovariectomy and improve Ca balance in young OVX rats.
Based on these results, we hypothesized that FLL could pro-
tect against bone loss via its actions on the axis of Ca homeo-
stasis. To determine whether the actions of FLL are mediated
Table 4. Bone mass measured by peripheral quantitative computerized tomography in rat femur.
(Mean values and standard errors for between six and eight rats per group)
Proximal metaphysis
BMD (mg/ccm)
Diaphysis BMD
(mg/ccm)
Diaphysis BMC
(mg/mm)
Distal metaphysis
BMD (mg/ccm)
Group§ Mean SEM Mean SEM Mean SEM Mean SEM
LCD
SVL 887·2 39·4 1204 20 8·62a 0·27 716·2 42·1
OVL 826·3 28·9 1152 18 7·59 0·18 560·3 9·7
SFL 947·8 13·7 1223 22 9·11b 0·26 651·8 33·0
OFL 860·9 11·6 1150 19 7·99 0·36 555·6 12·6
Two-way ANOVA (P value)
FLL 0·0726 0·6681 0·0377* 0·2062
OVX 0·0079** 0·0052** 0·0065** 0·0001***
MCD
SVM 985·1 22·7 1202 10 8·54 0·27 736·2 31·0
OVM 853·7 16·3 1122a 8 7·10 0·33 574·3 24·9
SFM 997·0 19·8 1228 15 9·25 0·41 753·1 22·6
OFM 873·0 18·9 1176b 17 7·74 0·35 606·7 47·2
Two-way ANOVA (P value)
FLL 0·4402 0·0121* 0·0418* 0·4908
OVX ,0·0001*** 0·0002*** 0·0003*** 0·0003***
HCD
SVH 1042·0 23·3 1259 10 9·72 0·26 778·7 38·0
OVH 825·1 29·0 1150 21 7·69 0·51 599·5 18·4
SFH 947·2 17·0 1231 22 9·74 1·00 736·3 16·9
OFH 885·2 16·9 1161 16 7·50 0·36 613·0† 22·4
Two-way ANOVA (P value)
FLL 0·4468 0·6229 0·8904 0·5753
OVX ,0·0001*** ,0·0001*** 0·0026** ,0·0001***
Effect of different dietary Ca level (P value)
Sham 0·0859 0·1335 0·1485 0·0581
OVX 0·6505 0·9263 0·5954 0·1695
LCD, low-Ca diet; MCD, medium-Ca diet; HCD, high-Ca diet; FLL, Fructus Ligustri Lucidi; OVX, ovariectomized; S, Sham; O, OVX; V, Vehicle; F, FLL;
L, LCD; M, MCD; H, HCD; BMD, bone mineral density; BMC, bone mineral content.
ab Mean values in columns of the same dietary-Ca level with unlike superscript are significantly different: P , 0·05.
†P , 0·05, compared with rats in OVL group.
*P , 0·05, **P , 0·01, ***P , 0·001, statistical analysis by two-way ANOVA.
§ Inter-group differences were analzed by one-way ANOVA, followed by Tukey’s post hoc test.
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through the Ca homeostasis axis, both Sham and OVX aged
Sprague-Dawley rats were subjected to different dietary regi-
men containing low, medium or high level of Ca content. The
results in the present study clearly demonstrated that FLL did
not offer additional benefit to HCD in protection against bone
loss in aged intact and OVX rats, suggesting that the bone pro-
tective effects of FLL extract are influenced by dietary Ca
levels. These results support our hypothesis that the actions
of FLL on bone are mediated through its positive effect on
Ca balance as diets containing high level of Ca alone
(HCD) could improve Ca balance in aged intact and OVX
rats to a level that prevent further improvement of Ca balance
and bone mass that could otherwise be achieved by FLL treat-
ments in rats fed MCD and LCD. It is also interesting to note
that FLL treatment can increase bone mass and bone strength
at different sites in both Sham and OVX aged rats fed MCD
and LCD, suggesting that the effect of FLL on bone are inde-
pendent of the oestrogen status of the animals.
The results in the present study also indicated that the
actions of FLL on bone were site-specific. It could protect
against the loss of bone mass and improve mechanical prop-
erty at the diaphysis, but not at the epiphysis, of appendicular
bones in aged rats. The results indicated that FLL preferen-
tially increased cortical bone mass, but not trabecular bone
mass, in appendicular bones in aged rats. In fact, similar
bone-compartment-specific actions were previously reported
in other studies when animals were treated with the complex
of rhIGF-I/IGFBP-520, retinoid21, long-chain n-3 PUFA22, or
daidzein23. All of these agents act solely on cortical bone,
but not on trabecular bone, in their experimental conditions.
Fig. 3. (a) Bone mineral densiy (BMD) and (b) bone mineral content (BMC)
of femoral diaphysis. Measurements for treatment groups (S, Sham; O, ovari-
ectomized; V, Vehicle; F, Fructus Ligustri Lucidi) on different diets (LCD, low-
Ca diet (L); MCD, medium-Ca diet; HCD, high-Ca diet) shown are: , SV; ,
SF; , OV; , OF. Values are expressed as means with standard errors
indicated by vertical bars (n 6–8). Inter-group differences were analyzed by
one-way ANOVA, followed by Tukey’s post hoc test. *P , 0·05, v. V-treated
group receiving similar treatment.
Fig. 4. Bone mineral density (BMD) of lumbar vertebra-2. Measurements
for treatment groups (S, Sham; O, ovariectomized; V, Vehicle; F, Fructus
Ligustri Lucidi) on different diets (LCD, low-Ca diet (L); MCD, medium-Ca
diet; HCD, high-Ca diet) shown are: , SV; , SF; , OV; , OF. Values
are expressed as means with standard errors indicated by vertical bars (n 6–
8). Inter-group differences were analyzed by one-way ANOVA, followed by
Tukey’s post hoc test. *P , 0·05, v. V-treated group; †P , 0·05, ††P,0·01,
v. SVL; ‡P , 0·05, ‡‡ P , 0·01, v. OVL.
Table 5. Two-way ANOVA analysis of the effects of ovariectomy (OVX)
and Fructus Ligustri Lucidi (FLL) in rats fed different Ca-containing
diets†, and different dietary Ca level in Sham and OVX rats on bone
mineral density of lumbar vertebra
OVX FLL
LCD 0·0078** 0·0150*
MCD 0·0276* 0·1316
HCD 0·0018** 0·2533
Different dietary Ca level
Sham 0·0057**
OVX 0·2513
LCD, low-Ca diet; MCD, medium-Ca diet; HCD, high-Ca diet.
† Effect of different Ca diets and herbal treatment, which are the two interventions
in the analysis of two-way ANOVA, was evaluated in Sham rats and OVX rats,
respectively.
*P , 0·05, **P , 0·01, statistical analysis by two-way ANOVA.
Table 6. Two-way ANOVA analysis of the effects of ovariectomy (OVX)
and Fructus Ligustri Lucidi (FLL) in rats fed different Ca-containing diet,
and different dietary Ca level in Sham and OVX rats on bone strength
of tibial diaphysis‡
OVX FLL
Maximal load Stiffness Maximal load Stiffness
LCD 0·3923 0·0813 0·0853 0·0167*
MCD 0·0033** 0·0125* 0·0139* 0·0056**
HCD 0·0987 0·3739 0·2766 0·2915
Different dietary Ca level
Maximal load Stiffness
Sham 0·0028** (0·0415†) ,0·0001*** (,0·0001†††)
OVX 0·5663 0·0526
LCD, low-Ca diet; MCD, medium-Ca diet; HCD, high-Ca diet.
‡ Effect of different Ca diets and herbal treatment, which are the two interventions
in the analysis of two-way ANOVA, was evaluated in Sham rats and OVX rats,
respectively.
*P , 0·05, **P , 0·01, ***P , 0·001, statistical analysis by two-way ANOVA.
†P , 0·05, †††P , 0·001, P value in parentheses showed the interaction between
Ca diets and FLL feeding.
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However, it should be noted that FLL improved spine BMD
in rats fed LCD, suggesting that FLL could also increase tra-
becular bone content in animals when the dietary Ca level was
low. The different effects of FLL observed in trabecular bone
of spine and appendicular bone might be due to the differences
in sensitivity of the trabecular bone at these two sites to Ca
restriction. A previous study reported that redistribution of
bone mass from axial to appendicular skeleton occurred in
rats receiving Ca restriction24, suggesting that trabecular
bone mass in spine would be preferentially reduced in
response to LCD feeding. Thus, the positive effect of FLL
on BMD in both Sham and OVX rats demonstrated at the
spine, but not at the appendicular sites, could be due to the
much reduced trabecular bone mass found at the spine in
response to LCD.
Our results indicated that either HCD alone or in combi-
nation with FLL could enhance bone mass at both the corti-
cial bone-rich diaphysis and trabecular bone-rich distal
metaphysis of tibia and femur in OVX rats when compared
to vehicle-treated OVX rats fed LCD. The results suggest
that Ca has a greater protective effect on bone than FLL
because treatment of aged OVX rats fed LCD with FLL
alone (OFL group) did not exhibit protective effects on
bone. The lack of bone protective effects of FLL extract in
OVX rats fed LCD indicate that the action of FLL on bone
requires the presence of sufficient supply of dietary Ca to
compensate for the bone loss due to the negative Ca balance
created by oestrogen deficiency in OVX rats. Nonetheless, the
effects of FLL cannot be disregarded as FLL, when combined
with HCD, preserved bone mass more favourably than HCD
alone. Similarly, BMD of lumbar vertebra in aged Sham
and OVX rats treated with FLL and HCD were higher than
those in corresponding group when fed LCD alone (Fig. 4).
These findings suggest that the combination of FLL and
HCD can positively influence bone mass and bone strength
in aged rats.
The fact that FLL treatment could promote calcification of
the extracellular matrix of osteoblastic cells suggests that FLL
could act directly on osteoblastic cells and promote bone for-
mation. Our results, however, showed that FLL extract did not
alter osteoblastic cell proliferation, suggesting that its positive
actions on bone might be at the later stage of osteoblastic cell
development. The observed enhancement of mineralization
may, at least partially, account for the increase of cortical
bone mass in the appendicular bones by promoting new
bone formation.
The present study is the first to reveal the bone protective
effects of FLL and its direct effects on the process of bone
mineralization. The fact that its bone protective actions are
not affected by oestrogen status suggests that its action
might be different from other phytooestrogen-containing
herbs. In addition, its actions on bone appear to be masked
by the consumption of HCD, suggesting that it might directly
work on the axis of Ca homeostasis. Future study will be
required to delineate the molecular mechanism involved in
bone protective effects of this herb and to identify the active
Fig. 5. (a) Maximal load and (b) stiffness of rat tibial diaphysis in three-point
bending test. Measurements for treatment groups (S, Sham; O, ovari-
ectomised; V, Vehicle; F, Fructus Ligustri Lucidi) on different diets (LCD, low-
Ca diet (L); MCD, medium-Ca diet; HCD, high- Ca diet) shown are: , SV;
, SF; , OV; , OF. Values are expressed as means with standard errors
indicated by vertical bars (n 10). Inter-group differences were analyzed by
one-way ANOVA, followed by Tukey’s post hoc test. *P , 0·05; **P , 0·01,
v. V-treated group receiving similar treatment.
Fig. 6. The extracellular levels of (a) Ca deposit and (b) phosphate (P)
deposit in rat osteoblast-like UMR 106 cells. Cells were cultured in mineraliz-
ing medium supplemented with vehicle (C) and Fructus Ligustri Lucidi (FLL)
extracts at the concentration of 0·1, 1, 10, 100mg/ml for 3 d ( ) and 6 d ( ).
Values are expressed as means with standard errors indicated by vertical
bars. Results are obtained from three independent experiments. *P , 0·05;
**P , 0·01; ***P , 0·001, v. C.
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fractions or constituents that could account for its biological
actions. Taken together, FLL could be considered as a poten-
tial alternative regimen for prevention and treatment of osteo-
porosis. It could increase bone mass and bone strength in aged
rats possibly through its actions on Ca homeostasis and bone
mineralization.
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